Best Practice & Research Clinical Rheumatology
Volume 22, Issue 3 , Pages 387-394 , June 2008

How to manage musculoskeletal conditions

  • Philip G. Conaghan, MB, BS, PhD, FRACP, FRCP (Professor of Musculoskeletal Medicine, Section of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds, UK)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44 113 392 4883; Fax: +44 113 392 4991.

References 

  1. Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bulletin of the World Health Organization. 2003;81(9):646–656
  2. Keenan AM, Tennant A, Fear J, et al. Impact of multiple joint problems on daily living tasks in people in the community over age fifty-five. Arthritis and Rheumatism. Oct 15 2006;55(5):757–764
  3. Kadam UT, Jordan K, Croft PR. Clinical comorbidity in patients with osteoarthritis: a case-control study of general practice consulters in England and Wales. Annals of the Rheumatic Diseases. 2004;63(4):408–414
  4. Dunlop DD, Manheim LM, Sohn MW, et al. Incidence of functional limitation in older adults: the impact of gender, race, and chronic conditions. Archives of Physical Medicine and Rehabilitation. 2002;83(7):964–971
  5. National Centre for Health Statistics . National health interview survey. Department of Health and Human Services; 1995;
  6. Jacobson L, Lindgren B. Vad kostar sjukdomarna? (What are the costs of illness?), Stockholm: Socialstyrelsen (National Board of Health and Welfare); 1996;
  7. Ward MM, Leigh JP, Fries JF, et al. Progression of functional disability in patients with rheumatoid arthritis. Associations with rheumatology subspecialty care. Archives of Internal Medicine. Oct 11 1993;153(19):2229–2237
  8. Clark JP, Hudak PL, Hawker GA, et al. The moving target: a qualitative study of elderly patients' decision-making regarding total joint replacement surgery. The Journal of Bone and Joint Surgery – American Volume. Jul 2004;86-A(7):1366–1374
  9. Ironside PM, Scheckel M, Wessels C, et al. Experiencing chronic illness: cocreating new understandings. Qualitative Health Research. Feb 2003;13(2):171–183
  10. Moore RA, Derry S, McQuay HJ, Paling J. What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non selective NSAIDs. Arthritis Research & Therapy. 2008;10(1):R20
  11. Kvien TK, Heiberg T, Hagen KB, et al. Minimal clinically important improvement/difference (MCII/MCID) and patient acceptable symptom state (PASS): what do these concepts mean?. Annals of the Rheumatic Diseases. Nov 2007;66(Suppl. 3):iii40–iii41
  12. Carr AJ, Higginson IJ. Are quality of life measures patient centred?. BMJ. 2001;322(7298):1357–1360
  13. Health Do . Improving chronic disease management. Department of Health; 2005;
  14. Roddy E, Zhang W, Doherty M, et al. Aerobic walking or strengthening exercise for osteoarthritis of the knee? A systematic review. Annals of the Rheumatic Diseases. Apr 2005;64(4):544–548
  15. White A, Foster NE, Cummings M, et al. Acupuncture treatment for chronic knee pain: a systematic review. Rheumatology. Mar 2007;46(3):384–390
  16. Warner TD, Mitchell JA, Warner TD, Mitchell JA. COX-2 selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugs. Lancet. Jan 19 2008;371(9608):270–273
  17. Kalso E, Edwards JE, Moore RA, et al. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain. Dec 2004;112(3):372–380
  18. Smolen JS, Aletaha D, Koeller M, et al. New therapies for treatment of rheumatoid arthritis. Lancet. Dec 1 2007;370(9602):1861–1874
  19. Ernst E. Complementary or alternative therapies for osteoarthritis. Nature Clinical Practice. Rheumatology. 2006;2(2):74–80

PII: S1521-6942(08)00029-6

doi: 10.1016/j.berh.2008.02.004

Best Practice & Research Clinical Rheumatology
Volume 22, Issue 3 , Pages 387-394 , June 2008

Article Tools